New insider activity at CME Group ( (CME) ) has taken place on February 15, 2025.
In a significant move, CME Group’s Sr MD Chief Commercial Officer, Julie Winkler, has divested 11,592 shares of the company’s stock, amounting to a sale worth $2,888,378. Meanwhile, the company’s Chief Transformation Officer, Ken Vroman, also executed a sale, offloading 5,066 shares with a total value of $1,266,500.
Recent Updates on CME stock
In recent developments, CME Group’s stock saw positive momentum following its impressive Q4 earnings report, which exceeded expectations with a 3% beat on earnings and a ~1% beat on revenues. This robust financial performance, coupled with record revenue and earnings for 2024, prompted several analysts to raise their price targets for CME Group. The company’s strong volume growth across various asset classes, particularly in the international and retail segments, and a record average daily volume of 26.9 million contracts in 2024 contributed to these upward revisions. Additionally, CME Group’s strategic investments, including cloud migration, and its ability to navigate regulatory challenges and competitive pressures, have reinforced confidence among analysts. Despite increased expenses, the company’s forward-looking guidance remains optimistic, projecting further growth and expansion in 2025.
More about CME Group
YTD Price Performance: 7.47%
Average Trading Volume: 2,079,412
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $90.13B